Patents by Inventor Meena

Meena has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10205770
    Abstract: A system is provided for integrating a feature rich application platform operating on a mobile device with a vehicle infotainment system. The system includes a head unit configured to control user interface devices including a display, a command entry device, and an audio output device. The head unit also includes computing resources and a communications interface. A content consumer application operates using the computing resources of the head unit, and is configured to communicate user generated commands over a communications interface to a content provider application executing on a mobile device. The content provider application is configured to direct the user generated commands to one of a plurality of sub-applications on the mobile device.
    Type: Grant
    Filed: January 8, 2013
    Date of Patent: February 12, 2019
    Assignee: HARMAN INTERNATIONAL INDUSTRIES, INCORPORATED
    Inventors: Arvin Baalu, Manu Malhotra, Sangeetha Venkateswaran, Omprakash Meena
  • Patent number: 10192007
    Abstract: A method implemented using one or more computer processors for estimating the density of a material in an annular space includes receiving detector data representative of scattered photons resulting from interaction of a material in an annular space with radiation from a radiation source and detected by a plurality of radiation detectors. The technique further includes performing a set of Monte Carlo simulations. The method further includes performing a principal component analysis on the set of Monte Carlo simulations to generate a principal component analysis model of the detector data. The method also includes estimating the density of the material at one or more locations within the annular space based upon the principal component analysis model and the detector data.
    Type: Grant
    Filed: December 5, 2014
    Date of Patent: January 29, 2019
    Assignee: General Electric Company
    Inventors: Michael Anthony Lexa, Meena Ganesh, John Brandon Laflen, John Edward Smaardyk, Donald Kenney Steinman
  • Publication number: 20190025252
    Abstract: A fluid testing system can be used to measure the levels of contaminants in a fluid system. The system can utilize anodic stripping voltammetry or some other chemical, electrical, or electrochemical process to measure the contaminant levels. Wire electrodes may be used to facilitate the tests. Unused portions of the electrode wires can be fed into the test chambers between tests to ensure clean and reliable electrodes for subsequent testing.
    Type: Application
    Filed: May 11, 2018
    Publication date: January 24, 2019
    Inventors: Meena Sankaran, Mazhar N. Ali, Harish Mehta
  • Publication number: 20190012624
    Abstract: The present invention generally relates to a real time analytical method and particularly relates to a method for digitally accumulating a consumer experience and analyse the collected data to provide a plurality of suggestion for improving a consumer experience on a target software. The present method allows a consumer oriented data acquisition and analytics in a short time span thus easing a client to optimize their digital platform and enhance the consumer experience. The present invention analyses a plurality of major parameters such as discoverability, accessibility, performance, omni-channel and perception and a plurality of minor parameters for providing analytics.
    Type: Application
    Filed: November 13, 2017
    Publication date: January 10, 2019
    Inventors: Brijesh PRABHAKAR, Sachin JAIN, Meena MALU, Karthikeyan BALASUBRAMANIAN, Deepika VAISHNAVE
  • Publication number: 20190008986
    Abstract: Among other things, the present disclosure relates to designed oligonucleotides, compositions, and methods thereof. In some embodiments, provided oligonucleotide compositions provide altered splicing of a transcript. In some embodiments, provided oligonucleotide compositions have low toxicity. In some embodiments, provided oligonucleotide compositions provide improved protein binding profiles. In some embodiments, provided oligonucleotide compositions have improved delivery. In some embodiments, provided oligonucleotide compositions have improved uptake. In some embodiments, the present disclosure provides methods for treatment of diseases using provided oligonucleotide compositions.
    Type: Application
    Filed: September 23, 2018
    Publication date: January 10, 2019
    Inventors: David Charles Donnell Butler, Sethumadhavan Divakaramenon, Christopher J. Francis, Maria David Frank-Kamenetsky, Naoki Iwamoto, Genliang Lu, Subramanian Marappan, Meena ., Chandra Vargeese, Gregory L. Verdine, Hailin Yang, Jason Jingxin Zhang
  • Patent number: 10160969
    Abstract: The present invention relates to chirally controlled oligonucleotides of select designs, chirally controlled oligonucleotide compositions, and methods of making and using the same. In some embodiments, a provided chirally controlled oligonucleotide composition provides different cleavage patterns of a nucleic acid polymer than a reference oligonucleotide composition. In some embodiments, a provided chirally controlled oligonucleotide composition provides single site cleavage within a complementary sequence of a nucleic acid polymer.
    Type: Grant
    Filed: January 16, 2015
    Date of Patent: December 25, 2018
    Assignee: WAVE LIFE SCIENCES LTD.
    Inventors: Meena, David Butler, Naoki Iwamoto, Nenad Svrzikapa, Gregory L. Verdine, Ivan Zlatev
  • Publication number: 20180334435
    Abstract: Compounds of formula (I) and pharmaceutically acceptable salts, esters, amides, or radiolabelled forms thereof, wherein R1, R2, and R3 are as defined in the specification, are useful in treating conditions or disorders prevented by or ameliorated by voltage-gated sodium channels, e.g., Nav1.7 and/or Nav1.8. Methods for making the compounds are disclosed. Also disclosed are pharmaceutical compositions of compounds of formula (I), and methods for using such compounds and compositions.
    Type: Application
    Filed: April 13, 2018
    Publication date: November 22, 2018
    Inventors: Andrew Bogdan, Marlon D. Cowart, David A. DeGoey, Tammie K. Jinkerson, John R. Koenig, Michael E. Kort, Bo Liu, Mark A. Matulenko, Derek W. Nelson, Meena V. Patel, Hillary Peltier, Marc J. Scanio, Brian D. Wakefield
  • Patent number: 10119976
    Abstract: The invention relates to methods of assessing a patient's risk of developing Progressive multifocal leukoencephalopathy (PML).
    Type: Grant
    Filed: May 27, 2014
    Date of Patent: November 6, 2018
    Assignee: Biogen MA Inc.
    Inventors: Gary Lewis Bloomgren, Carmen Bozic, Sophia Lee, Amy Pace, Tatiana Plavina, Meena Subramanyam
  • Publication number: 20180285476
    Abstract: Methods, systems, apparatuses, and computer program products are provided for intermixing expressions with other types of data in input controls. A system includes a processor and a memory that stores program code configured to be executed by the processor. The program code comprises a step configuration interface configured to receive, via a same input control, an expression as a first segment and a different type of data from an expression as a second segment. The program code further comprises a logic generator configured to generate a serialized representation that includes a serialized version of the first segment and a serialized version of the second segment.
    Type: Application
    Filed: January 11, 2018
    Publication date: October 4, 2018
    Inventors: Stephen Siciliano, Charles W. Lamanna, You Tang, Nitish Kumar Meena, Jeffrey S. Hollan, Balasubramanian Shyamsundar, Priti Sambandam
  • Patent number: 10058250
    Abstract: An apparatus can be provided which can include a laser arrangement which can be configured to provide a laser radiation, and can include an optical cavity. The optical cavity can include a dispersive optical first arrangement which can be configured to receive and disperse at least one first electro-magnetic radiation so as to provide at least one second electro-magnetic radiation. Such cavity can also include an active optical modulator second arrangement which can be configured to receive and modulate the at least one second radiation so as to provide at least one third electro-magnetic radiation. The optical cavity can further include a dispersive optical third arrangement which can be configured to receive and disperse at least one third electro-magnetic radiation so as to provide at least one fourth electro-magnetic radiation.
    Type: Grant
    Filed: March 9, 2017
    Date of Patent: August 28, 2018
    Assignee: The General Hospital Corporation
    Inventors: Benjamin Vakoc, Meena Siddiqui, Serhat Tozburun
  • Publication number: 20180222936
    Abstract: Described herein are methods for the synthesis of derivatives of thiosulfonate reagents. Said reagents have utility for the synthesis of phosphorothiotriesters from H-phosphonates in a stereospecific fashion.
    Type: Application
    Filed: March 30, 2018
    Publication date: August 9, 2018
    Inventors: Gregory L. Verdine, Meena, Naoki Iwamoto, David Charles Donnell Butler
  • Publication number: 20180216108
    Abstract: Among other things, the present disclosure relates to chirally controlled oligonucleotides of select designs, chirally controlled oligonucleotide compositions, and methods of making and using the same. In some embodiments, a provided chirally controlled oligonucleotide composition provides different cleavage patterns of a nucleic acid polymer than a reference oligonucleotide composition. In some embodiments, a provided chirally controlled oligonucleotide composition provides single site cleavage within a complementary sequence of a nucleic acid polymer. In some embodiments, a chirally controlled oligonucleotide composition has any sequence of bases, and/or pattern or base modifications, sugar modifications, backbone modifications and/or stereochemistry, or combination of these elements, described herein.
    Type: Application
    Filed: July 22, 2016
    Publication date: August 2, 2018
    Inventors: Chandra Vargeese, Meena, Nenad Svrzikapa, Susovan Mohapatra, Christopher J. Francis, Gregory L. Verdine, Anna Sokolovska
  • Patent number: 10000579
    Abstract: An integrated process for the recovery of a spectrum of commercially valuable products such as agar, cellulose, lipids, pigments and a liquid rich in minerals of agricultural importance directly from fresh seaweed without employing any catalyst driven in situ chemical conversions. Also solvents used during lipid extraction were shown to be used for three cycles without affecting the yield and quality of successive products. Furthermore, this new process is highly efficient and utilizes total seaweed raw material without any leftover biomass as solid waste.
    Type: Grant
    Filed: December 30, 2014
    Date of Patent: June 19, 2018
    Assignee: Council of Scientific & Industrial Research
    Inventors: Chennur Radhakrishna Reddy, Ravi Singh Baghel, Nitin Trivedi, Puja Kumari, Vishal Gupta, Kamlesh Prasad, Ramavatar Meena
  • Publication number: 20180165253
    Abstract: A system and method for providing management such as creation, manipulation, storage, control, and retrieval of digital content for a company on a global basis. Digital content is created and stored in, for example, the eXtensible Markup Language (XML) format using the relationship between component mapping information and content information comprising webpage components. The XML data is developed by defining page components, mapping the components on a page and indexing the page for future retrieval of the page. The data is then stored in a single database, as segments related to the page, for call-up by a user.
    Type: Application
    Filed: November 20, 2017
    Publication date: June 14, 2018
    Inventors: Andrea Bimson, Jin Chyung, Meena Gopakumar, Lorraine Miranda, Biswajit Sarkar, Shashikant Rao, Kaustubh Kunte
  • Patent number: 9982257
    Abstract: The present invention relates to chirally controlled oligonucleotides, chirally controlled oligonucleotide compositions, and the method of making and using the same. The invention specifically encompasses the identification of the source of certain problems with prior methodologies for preparing chiral oligonucleotides, including problems that prohibit preparation of fully chirally controlled compositions, particularly compositions comprising a plurality of oligonucleotide types. In some embodiments, the present invention provides chirally controlled oligonucleotide compositions. In some embodiments, the present invention provides methods of making chirally controlled oligonucleotides and chirally controlled oligonucleotide compositions.
    Type: Grant
    Filed: July 12, 2013
    Date of Patent: May 29, 2018
    Assignee: WAVE LIFE SCIENCES LTD.
    Inventors: David Butler, Naoki Iwamoto, Meena, Nenad Svrzikapa, Gregory L. Verdine, Ivan Zlatev
  • Patent number: 9969693
    Abstract: Compounds of formula (I) and pharmaceutically acceptable salts, esters, amides, or radiolabelled forms thereof, wherein R1, R2, and R3 are as defined in the specification, are useful in treating conditions or disorders prevented by or ameliorated by voltage-gated sodium channels, e.g., Nav 1.7 and/or Nav 1.8. Methods for making the compounds are disclosed. Also disclosed are pharmaceutical compositions of compounds of formula (I), and methods for using such compounds and compositions.
    Type: Grant
    Filed: August 17, 2016
    Date of Patent: May 15, 2018
    Assignee: AbbVie Inc.
    Inventors: Andrew Bogdan, Marlon D. Cowart, David A. DeGoey, Tammie K. Jinkerson, John R. Koenig, Michael E. Kort, Bo Liu, Mark A. Matulenko, Derek W. Nelson, Meena V. Patel, Hillary Peltier, Marc J. Scanio, Brian D. Wakefield
  • Patent number: 9970899
    Abstract: A fluid testing system can be used to measure the levels of contaminants in a fluid system. The system can utilize anodic stripping voltammetry or some other chemical, electrical, or electrochemical process to measure the contaminant levels. Wire electrodes may be used to facilitate the tests. Unused portions of the electrode wires can be fed into the test chambers between tests to ensure clean and reliable electrodes for subsequent testing.
    Type: Grant
    Filed: July 13, 2017
    Date of Patent: May 15, 2018
    Assignee: KETOS, INC.
    Inventors: Meena Sankaran, Mazhar N. Ali, Harish Mehta
  • Patent number: 9964625
    Abstract: A fault monitoring system for an electrical substation includes one or more arrays of acoustic sensors placed around a substation boundary and configured to measure acoustic pressure waves. A processing circuitry in the fault monitoring system localizes and identifies faults in the substation and includes a sound source localization module to identify an area of a sound source based on the acoustic pressure waves. A beamforming module of processing circuitry provides enhanced acoustic pressure waves by eliminating background noise and interfering noise from the acoustic pressure waves and a component signature classification module in the processing circuitry compares enhanced acoustic pressure waves with component signatures to classify the acoustic pressure waves into various events to detect faults in the electrical substation.
    Type: Grant
    Filed: June 27, 2011
    Date of Patent: May 8, 2018
    Assignee: General Electric Company
    Inventors: Tarik Yardibi, Meena Ganesh, Timothy Lee Johnson
  • Patent number: 9932327
    Abstract: The present invention relates to the rohitukine (5,7-dihydroxy-8-(3-hydroxy-1-methyl-piperidin-4-yl)-4H-chromen-4-ones) analogs of formula A and pharmaceutically acceptable salts thereof. In addition, the invention relates to pharmaceutically acceptable compositions comprising at least one such compound, and methods of using the compounds for treating or preventing various proliferative disorders such as melanoma, leukemia, breast cancer and prostate cancer etc. [insert Formula A here] wherein, n=0 or 1, when n=1, the dotted line indicates the double bond.
    Type: Grant
    Filed: April 16, 2014
    Date of Patent: April 3, 2018
    Assignee: The Council of Scientific & Industrial Research
    Inventors: Ram A. Vishwakarma, Sandip B. Bharate, Shashi Bhushan, Dilip M. Mondhe, Shreyans K. Jain, Samdarshi Meena, Santosh K. Guru, Anup S. Pathania, Suresh Kumar, Akanksha Behl, Mubashir J. Mintoo, Sonali S. Bharate, Prashant Joshi
  • Publication number: 20180088127
    Abstract: The invention relates to methods and products for the identification of a clinically significant immune response in subjects treated with a therapeutic protein. Aspects of the invention relate to methods and compositions for identifying a clinically significant immune response in patients treated with therapeutic amounts of a VLA4 binding antibody (e.g., natalizumab).
    Type: Application
    Filed: June 7, 2017
    Publication date: March 29, 2018
    Applicant: Biogen MA Inc.
    Inventors: Meena Subramanyam, Lakshmi Amaravadi, Eric Wakshull, Frances Lynn, Michael Panzara, Robin McDaid Barbour, Julie Elizabeth Taylor